SRPT

Sarepta Therapeutics
SRPT

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$5.77B
EV
$5.76B
Shares Outstanding
97.03M
Beta
0.92

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$147.33
P/E 2025E
9.32x
P/Revenue 2025E
1.89x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Sarepta Therapeutics, Inc.

gainify
SRPT

Sarepta Therapeutics, Inc.

SRPT

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection...

Sector

Healthcare

Industry

Biotechnology

CEO

Ingram, Douglas

Employees

1,372

IPO Date

1997-06-04

Headquarters

215 First Street, Suite 415, Cambridge, Massachusetts, 02142, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved